Strain Information | |
---|---|
Image | |
BRC No. | RBRC04200 |
Type | Targeted Mutation![]() |
Species | Mus musculus |
Strain name | B6.129P2-Cxcl12<tm2Tng> |
Former Common name | CXCL12-GFP |
H-2 Haplotype | |
ES Cell line | E14.1 [129P2/OlaHsd] |
Background strain | |
Appearance | |
Strain development | Developed by Takashi Nagasawa, Research Institute, Osaka Medical Center for Maternal and Child Health. E14.1 ES cells were used. The mutant mice were backcrossed to C57BL/6J for 6 times, and then maintained by sibling mating. |
Strain description | CXCL12-GFP knock-in mice. Exon 1 of the Cxcl12 gene was replaced with a GFP expression cassette. |
Colony maintenance | Heterozygote x Wild-type [or Crossing to C57BL/6JJcl] |
References | Long-term hematopoietic stem cells require stromal cell-derived factor-1 for colonizing bone marrow during ontogeny. Ara T, Tokoyoda K, Sugiyama T, Egawa T, Kawabata K, Nagasawa T Immunity, 19, 257-267 (2003). 12932359 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |||||||
---|---|---|---|---|---|---|---|
Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
Cxcl12 MGI:103556 | C-X-C motif chemokine ligand 12 | 6 | Cxcl12<tm2Tng> MGI:3579534 | targeted mutation 2, Takashi Nagasawa | |||
EGFP | Enhanced Green Fluorescent Protein (Aequorea victoria) | 6 | EGFP | ||||
loxP | phage P1 loxP | 6 | loxP | ||||
loxP | phage P1 loxP | 6 | loxP | ||||
loxP | phage P1 loxP | 6 | loxP | ||||
neo | neomycin resistance gene (E. coli) | 6 | mouse phosphoglycerate kinase promoter (PGK promoter) |
Phenotype | |
---|---|
Annotation by Mammalian phenotyhpe ontology | |
Detailed phenotype data |
Ordering Information | |
---|---|
Donor DNA | Jellyfish EGFP cDNA, SV40 PolyA signal, Phage P1 loxP sites, smouse phosphoglycerate kinase promoter (PGK promoter), E. coli neo, Mouse Cxcl12 genomic DNA |
Research application | Cre/loxP system Fluorescent Proteins/lacZ System |
Specific Term and Conditions | Prior to requesting the BIOLOGICAL RESOURCE, the RECIPIENT is requested to make a Material Transfer Agreement with the DEPOSITOR. For use of the BIOLOGICAL RESOURCE by a for-profit institution, the RECIPIENT must reach agreement on terms and conditions of use of it with DEPOSITOR and must obtain a prior written consent form the DEPOSITOR. |
Depositor | Takashi Nagasawa (Kyoto University) |
Strain Status | ![]() ![]() |
Strain Availability | Recovered litters from cryopreserved embryos (2 to 4 months) Cryopreserved sperm (within 1 month) Cryopreserved embryos (within 1 month) |
Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- Mouse of the Month Dec 2014 |
BRC mice in Publications |
---|
No Data |